Alpenglow Biosciences and Mayo Clinic enter collaboration agreement to advance pathology and drug development through 3D spatial biology portfolioDynamk CapitalApril 12, 2023
Portfolio Company Vectron Biosolutions Recently Published in Frontiers in Chemical Engineering portfolioDynamk CapitalMarch 20, 2023
RoosterBio & Repligen Collaborate to Advance Scalable Exosome Bioprocessing Dynamk CapitalMarch 15, 2023
Curi Bio Names Nicholas Geisse, Ph.D., as New Chief Executive Officer portfolioDynamk CapitalFebruary 16, 2023
Portfolio Company Envisagenics Featured in Recent Wuxi AppTec Interview Dynamk CapitalFebruary 10, 2023
Portfolio Company BitBio Recently Announced a Partnership with Automata portfolioDynamk CapitalFebruary 10, 2023
Sartorius Collaborates with RoosterBio to Advance Downstream Purification Processes for the Manufacture of Exosomes Dynamk CapitalJanuary 10, 2023
Portfolio Company Envisagenics enters into Multi-Year Collaboration with BMS portfolioDynamk CapitalNovember 29, 2022
Daniella Kranjac Recognized in Fierce Pharma's "Fiercest Women in Life Sciences" 2022 Dynamk CapitalNovember 14, 2022
Portfolio Co. Vectron Biosolutions Partners with Plant-Based Foods Manufacturer portfolioDynamk CapitalOctober 26, 2022
Dynamk Capital makes Inc. Magazine 2022 Founder-Friendly Investors list Dynamk CapitalOctober 4, 2022Dynamk Capital
Daniella Kranjac nominated for "Lifetime Luminary" award at Biotech Week Boston Dynamk CapitalSeptember 13, 2022
Portfolio Co. RoosterBio and AGC Biologics Announce Collaboration portfolioDynamk CapitalAugust 23, 2022
Dynamk Capital Co-Leads $21M Vernal Biosciences round along with Ampersand Capital Partners portfolioDynamk CapitalJune 2, 2022
Bionter AG secures $3 Million in Series Seed Financing Led by Dynamk Capital portfolioDynamk CapitalApril 27, 2022
